Trial · NCT07343128
Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia
NCT07343128, Phase 2, Phase 3, Completed, Sanliurfa Education and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia. Trials, record NCT07343128. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07343128
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia
- NCT number
- NCT07343128
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 68 participants, actual
- Lead sponsor
- Sanliurfa Education and Research Hospital
- Conditions
- Fibromyalgia
- Interventions
- Lidocaine and Dexamethasone, Normal Saline
- First posted
- 2026-01-15
- Last updated
- 2026-01-16
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Fibromyalgia Impact Questionnaire Revised (FIQR) Total Score | Baseline to 1 week after the first injection | The FIQR is a 21-item validated instrument that assesses the overall impact of fibromyalgia on physical function, overall impact, and symptoms. Total score ranges from 0 to 100, with higher scores indicating greater disease impact. Change from baseline to 1 week is the primary endpoint. |
| Secondary | Change in FIQR Total Score at 1 Month | Baseline to 1 month | Change in FIQR total score from baseline to 1 month (3 weeks after the second injection). |
| Secondary | Change in Numerical Rating Scale (NRS) Pain Score | Baseline, 1 week, and 1 month | Pain intensity over the previous week assessed using an 11-point NRS (0 = no pain, 10 = worst pain imaginable). Change from baseline to 1 week and 1 month. |
| Secondary | FIQR Responder Rates (≥30% and ≥50% Improvement) | 1 week and 1 month | Percentage of patients achieving at least 30% and at least 50% reduction in FIQR total score from baseline. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 42530408 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07343128
GET https://conductscience.org/api/trials/v1/NCT07343128/registered